| COVID-19 and cardiovascular disease KJ Clerkin, JA Fried, J Raikhelkar, G Sayer, JM Griffin, A Masoumi, ... Circulation 141 (20), 1648-1655, 2020 | 2233 | 2020 |
| Indications for and findings on transthoracic echocardiography in COVID-19 SS Jain, Q Liu, J Raikhelkar, J Fried, P Elias, TJ Poterucha, EM DeFilippis, ... Journal of the American Society of Echocardiography 33 (10), 1278-1284, 2020 | 102 | 2020 |
| ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review JM Griffin, JL Rosenthal, JL Grodin, MS Maurer, M Grogan, RK Cheng Cardio Oncology 3 (4), 488-505, 2021 | 86 | 2021 |
| Pathophysiology and therapeutic approaches to cardiac amyloidosis JM Griffin, H Rosenblum, MS Maurer Circulation research 128 (10), 1554-1575, 2021 | 80 | 2021 |
| Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: a test in evolution TJ Poterucha, P Elias, S Bokhari, AJ Einstein, A DeLuca, M Kinkhabwala, ... Cardiovascular Imaging 14 (6), 1221-1231, 2021 | 62 | 2021 |
| The prognostic value of electrocardiogram at presentation to emergency department in patients with COVID-19 P Elias, TJ Poterucha, SS Jain, G Sayer, J Raikhelkar, J Fried, K Clerkin, ... Mayo Clinic Proceedings 95 (10), 2099-2109, 2020 | 59 | 2020 |
| Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review NA Gilotra, JM Griffin, N Pavlovic, BA Houston, J Chasler, C Goetz, ... Journal of cardiac failure 28 (1), 113-132, 2022 | 44 | 2022 |
| Admission cardiac diagnostic testing with electrocardiography and troponin measurement prognosticates increased 30‐day mortality in COVID‐19 TJ Poterucha, P Elias, SS Jain, G Sayer, B Redfors, D Burkhoff, ... Journal of the American Heart Association 10 (1), e018476, 2021 | 43 | 2021 |
| ATTR epidemiology, genetics, and prognostic factors CA Obi, WC Mostertz, JM Griffin, DP Judge Methodist DeBakey cardiovascular journal 18 (2), 17, 2022 | 37 | 2022 |
| Clinical and imaging response to tumor necrosis factor alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience NA Gilotra, AL Wand, A Pillarisetty, M Devraj, N Pavlovic, S Ahmed, ... Journal of cardiac failure 27 (1), 83-91, 2021 | 34 | 2021 |
| Lack of association between neurohormonal blockade and survival in transthyretin cardiac amyloidosis RK Cheng, A Vasbinder, WC Levy, P Goyal, JM Griffin, DJ Leedy, ... Journal of the American Heart Association 10 (24), e022859, 2021 | 30 | 2021 |
| The burden of ventricular arrhythmias following left ventricular assist device implantation JM Griffin, JN Katz Arrhythmia & Electrophysiology Review 3 (3), 145, 2014 | 30 | 2014 |
| Remote cardiac monitoring in patients with heart failure: a review PJ Kennel, H Rosenblum, KM Axsom, S Alishetti, M Brener, E Horn, ... JAMA cardiology 7 (5), 556-564, 2022 | 29 | 2022 |
| Systemic embolism in amyloid transthyretin cardiomyopathy S Vilches, M Fontana, E Gonzalez‐Lopez, L Mitrani, G Saturi, M Renju, ... European journal of heart failure 24 (8), 1387-1396, 2022 | 28 | 2022 |
| Impact of temporary percutaneous mechanical circulatory support before transplantation in the 2018 heart allocation system KJ Clerkin, O Salako, JA Fried, JM Griffin, J Raikhelkar, R Jain, ... Heart Failure 10 (1), 12-23, 2022 | 27 | 2022 |
| Impact of interatrial shunts on invasive hemodynamics and exercise tolerance in patients with heart failure JM Griffin, BA Borlaug, J Komtebedde, SE Litwin, SJ Shah, DM Kaye, ... Journal of the American Heart Association 9 (17), e016760, 2020 | 26 | 2020 |
| Management of cardiac sarcoidosis using mycophenolate mofetil as a steroid-sparing agent JM Griffin, J Chasler, AL Wand, DR Okada, JN Smith, E Saad, H Tandri, ... Journal of cardiac failure 27 (12), 1348-1358, 2021 | 25 | 2021 |
| Sex differences in the phenotype of transthyretin cardiac amyloidosis due to Val122Ile mutation: insights from noninvasive pressure–volume analysis J Batra, H Rosenblum, EM Defilippis, JM Griffin, SE Saith, D Gamino, ... Journal of cardiac failure 27 (1), 67-74, 2021 | 24 | 2021 |
| Transthyretin cardiac amyloidosis: a treatable form of heart failure with a preserved ejection fraction JM Griffin, MS Maurer Trends in cardiovascular medicine 31 (1), 59-66, 2021 | 24 | 2021 |
| Myocardial dysfunction and heart failure in rheumatoid arthritis E Park, J Griffin, JM Bathon Arthritis & Rheumatology 74 (2), 184-199, 2022 | 22 | 2022 |
